Evidence map›Paper›PMID 37602387›Full record

ArticleStroke2023

Safety Outcomes of Mechanical Thrombectomy Versus Combined Thrombectomy and Intravenous Thrombolysis in Tandem Lesions.

Aaron Rodriguez-Calienes, Milagros Galecio-Castillo, Mudassir Farooqui, Ameer E Hassan, Mouhammad A Jumaa, Afshin A Divani, Marc Ribo, Michael Abraham, Nils H Petersen, Johanna Fifi and 27 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Stroke, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 5 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 5 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors at 17 institutions in 4 countries.

Aaron Rodriguez-CalienesDepartment of Neurology, University of Iowa Hospitals and Clinics, Iowa City (A.R.-C., M.G.-C., M.F., D.Q.-O., J.V.-S.).ORCID 0000-0002-8413-6954
Milagros Galecio-CastilloDepartment of Neurology, University of Iowa Hospitals and Clinics, Iowa City (A.R.-C., M.G.-C., M.F., D.Q.-O., J.V.-S.).ORCID 0000-0002-8107-9632
Mudassir FarooquiDepartment of Neurology, University of Iowa Hospitals and Clinics, Iowa City (A.R.-C., M.G.-C., M.F., D.Q.-O., J.V.-S.).ORCID 0000-0003-3697-5697
Ameer E HassanDepartment of Neurology, Valley Baptist Medical Center/ University of Texas Rio Grande Valley, Harlingen, TX (A.E.H., W.G.T.).ORCID 0000-0002-7148-7616
Mouhammad A JumaaDepartment of Neurology, ProMedica Toledo Hospital, OH (M.A.J., H.A.).ORCID 0000-0002-7165-797X
Afshin A DivaniDepartment of Neurology, University of New Mexico Health Science Center, Albuquerque (A.A.D., A.I.).ORCID 0000-0001-8448-0758
Marc RiboDepartment of Neurology, Hospital Vall d'Hebron, Barcelona, Spain (M.R., F.R.).ORCID 0000-0001-9242-043X
Michael AbrahamDepartment of Neurology, University of Kansas Medical Center (M.A., A.Q.).ORCID 0000-0003-0407-654X
Nils H PetersenDepartment of Neurology, Yale University School of Medicine, New Haven, CT (N.H.P., L.B.).ORCID 0000-0001-9711-3340
Johanna FifiDepartment of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York (J.F., S.M.).ORCID 0000-0001-7786-5668
Waldo R GuerreroDepartment of Neurology and Brain Repair, University of South Florida, Tampa (W.R.G., M.M.).ORCID 0000-0002-4781-3944
Amer M MalikDepartment of Neurology, University of Miami Miller School of Medicine, FL (A.M.M., D.R.Y.).ORCID 0000-0003-2209-3167
James E SieglerCooper Neurological Institute, Cooper University Hospital, Camden, NJ (J.E.S., N.V., T.J.).ORCID 0000-0003-0287-3967
Thanh N NguyenDepartment of Neurology, Boston Medical Center (T.N.N., M.A.).ORCID 0000-0002-2810-1685
Albert J YooTexas Stroke Institute, Dallas-Fort Worth (A.J.Y., J.S.).ORCID 0000-0002-7657-142X
Guillermo LinaresDepartment of Neurology, Saint Louis University, St. Louis, MO (G.L., W.G.).ORCID 0000-0001-8694-2645
Nazli JanjuaAsia Pacific Comprehensive Stroke Institute, Pomona Valley Hospital Medical Center, CA (N.J., C.T.).ORCID 0000-0002-7624-3055
Darko Quispe-OrozcoDepartment of Neurology, University of Iowa Hospitals and Clinics, Iowa City (A.R.-C., M.G.-C., M.F., D.Q.-O., J.V.-S.).ORCID 0000-0003-3627-5439
Wondwossen G TekleDepartment of Neurology, Valley Baptist Medical Center/ University of Texas Rio Grande Valley, Harlingen, TX (A.E.H., W.G.T.).ORCID 0000-0001-5556-5699
Hisham AlhajalaDepartment of Neurology, ProMedica Toledo Hospital, OH (M.A.J., H.A.).ORCID 0009-0006-1301-1245
Asad IkramDepartment of Neurology, University of New Mexico Health Science Center, Albuquerque (A.A.D., A.I.).ORCID 0000-0002-0532-8991
Federica RizzoDepartment of Neurology, Hospital Vall d'Hebron, Barcelona, Spain (M.R., F.R.).ORCID 0000-0002-5945-8222
Abid QureshiDepartment of Neurology, University of Kansas Medical Center (M.A., A.Q.).ORCID 0000-0002-1498-6638
Liza BegunovaDepartment of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York (J.F., S.M.).ORCID 0000-0003-0222-2347
Stavros MatsoukaDepartment of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York (J.F., S.M.).ORCID 0000-0001-5902-0637
Nicholas VigilanteCooper Neurological Institute, Cooper University Hospital, Camden, NJ (J.E.S., N.V., T.J.).ORCID 0000-0003-0540-4816
Sergio Salazar-MarioniDepartment of Neurology, UT Health McGovern Medical School, Houston, TX (S.S.-M., S.S.).ORCID 0000-0002-2722-7542
Mohamad AbdalkaderDepartment of Neurology, Boston Medical Center (T.N.N., M.A.).ORCID 0000-0002-9528-301X
Weston GordonDepartment of Neurology, Saint Louis University, St. Louis, MO (G.L., W.G.).ORCID 0000-0003-4008-3536
Jazba SoomroTexas Stroke Institute, Dallas-Fort Worth (A.J.Y., J.S.).ORCID 0000-0002-6981-7540
Charoskon TurabovaAsia Pacific Comprehensive Stroke Institute, Pomona Valley Hospital Medical Center, CA (N.J., C.T.).ORCID 0009-0001-5179-9209
Juan Vivanco-SuarezDepartment of Neurology, University of Iowa Hospitals and Clinics, Iowa City (A.R.-C., M.G.-C., M.F., D.Q.-O., J.V.-S.).ORCID 0000-0001-5326-1907
Maxim MokinDepartment of Neurology and Brain Repair, University of South Florida, Tampa (W.R.G., M.M.).ORCID 0000-0003-4270-8667
Dileep R YavagalDepartment of Neurology, University of Miami Miller School of Medicine, FL (A.M.M., D.R.Y.).ORCID 0000-0003-4739-0133
Tudor JovinCooper Neurological Institute, Cooper University Hospital, Camden, NJ (J.E.S., N.V., T.J.).ORCID 0000-0002-2619-6975
Sunil Sheth *Department of Neurology, UT Health McGovern Medical School, Houston, TX (S.S.-M., S.S.).ORCID 0000-0003-0602-8509
Santiago Ortega-Gutierrez *Department of Neurology, Neurosurgery & Radiology, University of Iowa Hospitals and Clinics, Iowa City (S.O.-G.).ORCID 0000-0002-3408-1297
University of Iowa Hospitals and Clinics · USCooper University Hospital · USIcahn School of Medicine at Mount Sinai · USTwitter (United States) · USJPS Health Network · USPomona Valley Hospital Medical Center · USProMedica Toledo Hospital · USSaint Louis University · USThe University of Texas Health Science Center · USUniversity of Miami · USUniversity of New Mexico · USUniversity of South Florida · USVall d'Hebron Hospital Universitari · ESValley Baptist Medical Center · USBoston Medical Center · USUniversidad Científica del Sur · PEYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
University of New Mexico (UNM) Center for Brain Recovery and RepairP20GM109089 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI BOYCE, ANDREW · 2015 to 2024
$22.7M
Geospatial modeling for stroke careR01NS127114 · NINDS · UNIVERSITY OF IOWA · PI Grant D Brown, Nicholas M. Mohr · 2022 to 2026
$2.5M
Precision blood pressure management after endovascular stroke therapy based on real-time autoregulation measurementsK23NS110980 · NINDS · YALE UNIVERSITY · PI PETERSEN, NILS H. · 2020 to 2024
$951k
Noninvasive Vagus Nerve Stimulation for Treatment of Brain Injury (nVNS-TBI) in RatsR21NS130423 · NINDS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI DIVANI, AFSHIN ANDRE · 2022 to 2022
$419k
Novel risk stratification score for patients presenting with acute Cerebral Venous Sinus ThrombosisR03NS126804 · NINDS · UNIVERSITY OF IOWA · PI ORTEGA-GUTIERREZ, SANTIAGO · 2023 to 2024
$156k
NCATS NIH HHS UL1 TR001863NIGMS NIH HHS P20 GM109089NINDS NIH HHS K23 NS110980NINDS NIH HHS R01 NS127114NINDS NIH HHS R03 NS126804NINDS NIH HHS R21 NS130423
6 · The paper itself

Abstract

backgroundWe aimed to describe the safety and efficacy of mechanical thrombectomy (MT) with or without intravenous thrombolysis (IVT) for patients with tandem lesions and whether using intraprocedural antiplatelet therapy influences MT's safety with IVT treatment.

methodsThis is a subanalysis of a pooled, multicenter cohort of patients with acute anterior circulation tandem lesions treated with MT from 16 stroke centers between January 2015 and December 2020. Primary outcomes included symptomatic intracranial hemorrhage (sICH) and parenchymal hematoma type 2. Additional outcomes included hemorrhagic transformation, successful reperfusion (modified Thrombolysis in Cerebral Infarction score 2b-3), complete reperfusion (modified Thrombolysis in Cerebral Infarction score 3), favorable functional outcome (90-day modified Rankin Scale score 0-2), excellent functional outcome (90-day modified Rankin Scale score 0-1), in-hospital mortality, and 90-day mortality.

resultsOf 691 patients, 512 were included (218 underwent IVT+MT and 294 MT alone). There was no difference in the risk of sICH (adjusted odds ratio [aOR], 1.22 [95% CI, 0.60-2.51];

conclusionsOur study showed that the combination of IVT with MT for tandem lesions did not increase the overall risk of sICH, parenchymal hematoma type 2, or overall hemorrhagic transformation independently of the cervical revascularization technique used. However, intraprocedural intravenous antiplatelet therapy during acute stent implantation might be associated with an increased risk of sICH in patients who received IVT before MT. Importantly, IVT+MT treatment was associated with a higher rate of favorable functional outcomes at 90 days.

Indexed as

Brain IschemiaMechanical ThrombolysisStrokeCerebral InfarctionFibrinolytic AgentsHematomaHumansIntracranial HemorrhagesPlatelet Aggregation InhibitorsThrombectomyThrombolytic TherapyTreatment OutcomeFibrinolytic AgentsPlatelet Aggregation Inhibitorsintracranial hemorrhagereperfusionstrokethrombectomy

Identifiers

PMID37602387
PMCPMC10599264
OpenAlexW4386020038

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.